Diagnóstico y seguimiento del feto con restricción del crecimiento intrauterino (RCIU) y del feto pequeño para la edad gestacional (PEG). Consenso Colombiano*

  • José Enrique Sanín-Blair
  • Jaime Gómez-Díaz
  • Jorge Ramírez
  • Carlos Alberto Mejía
  • Óscar Medina
  • José Vélez

Resumen

Objetivo: dar a conocer a los participantes en el cuidado de la salud de la mujer embarazada, los más recientes avances y recomendaciones clínicas de un tema controversial que es causa importante de morbimortalidad perinatal en Colombia.

Metodología: se revisaron las bases de datos Cochrane, Medline y Embase, además de la base latinoamericana SciELO, libros de la especialidad y consensos de otras sociedades científicas en búsqueda de estudios diagnósticos, revisiones sistemáticas, estudios aleatorizados y metaanálisis relativos a los términos: “restricción de crecimiento intrauterino” y “pequeño para la edad gestacional” en el período comprendido entre 1995-2009. A partir de esto, se realizó un manuscrito inicial, el cual fue sometido a discusión por medio de Internet. Posteriormente, el manuscrito final fue discutido y modificado en la ciudad de Medellín (Colombia), en el marco del congreso de Medicina Fetal S.A. en septiembre de 2008.

Resultados: teniendo en cuenta la evidencia disponible, se presentó una guía para el manejo del feto PEG y con RCIU, la cual puede ser aplicada a Colombia.

Conclusiones: este tema genera controversia debido a la falta de evidencia científica para la aplicación de algunas definiciones y pruebas diagnósticas en su manejo.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

José Enrique Sanín-Blair

Gineco-obstetra. Coordinador del Consenso Colombiano de RCIU. Especialista en Medicina Materno-Fetal. Clínica Universitaria Bolivariana, Medellín (Colombia). 

Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).

 
Jaime Gómez-Díaz
Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).
Jorge Ramírez
Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).
Carlos Alberto Mejía
Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).
Óscar Medina
Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).
José Vélez
Gineco-obstetra. Especialista en Ultrasonido. Medicina Fetal S.A, Medellín (Colombia).

Referencias bibliográficas

Ville Y, Nyberg DA. Growth, Doppler and fetal assessment. En: Nyberg DA, McGahan JP, Pretorius DH, Pilu G, editors. Diagnostic imaging of fetal anomalies. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 31-58.

Manning FA. General principles and applications of ultrasonography. En: Creasy RK, Resnik R, editors. Maternal-fetal medicine. 4th ed. Philadelphia: W.B. Saunders Company; 1999. p. 169-206.

Figueras F, Gratacos E. Maneig de les alteracions per defecte del creixement fetal. Servicio de Medicina Materno Fetal. Institut Clínic de Ginecologia, Obstetrícia i Neonatología (ICGON), Hospital Clínic de Barcelona; 2007.

Sanin-Blair JE, Cuartas A. Restricción del crecimiento intrauterino. En: Botero J, Jubiz A, Henao G, eds. Obstetricia y Ginecología-Texto integrado. 8a ed. Bogotá: Editorial Québec World; 2008. p. 242-44.

ACOG practice bulletin No. 12. Washington, DC: American College of Obstetricians and Gynecologists; 2000.

Gratacós E, Carreras E, Higueras T, Becker J, Delgado J, López J, et al. Protocolo de incorporación del Doppler en el diagnóstico y control del feto RCIU o bajo peso; 2003.

Baschat A. Fetal Growth disorders. En: James DK, Steer PJ, Weiner CP, Gonik B. High risk obstetrics: management options. 3rd ed. Elsevier editorial; 2005. p. 240-72.

Departamento Administrativo Nacional de Estadística -DANE. Visitado en 2009 Jul 16. Disponible en http://www.dane.gov.co

Sacket DL. Evidence-based Medicine: How to Practice and Teach EBM. 2nd ed. NewYork: Churchill Livingstone; 2000. p. 1-252.

Hadlock FP, Harris RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body and femur measurements-a prospective study. Am J Obstet Gynecol 1985;151:333-7.

Montoya-Restrepo NE, Correa-Morales JC. Curvas de peso al nacer. Rev Salud Pública 2007;9:1-10.

Lagos R, Espinoza R, Echeverría P, Graf D, Sepúlveda JD, Orellana JJ. Gráfica regional de crecimiento fetal normal. Rev Hosp Mat Inf Ramón Sardá 2002;21:3-10.

González R, Gómez R, Castro R, Nien JK, Merino P, Etchegaray A, et al. Curva nacional de distribución de peso al nacer según edad gestacional: Chile, 1993 a 2000. Rev Med Chile 2004;132:1155-65.

Espinoza R, Lagos R, Guerra F. Guía para restricción de crecimiento intrauterino; 2003.

Boletín CLAP 19/94: Normatización de ecografías obstétricas. Montevideo, Uruguay; 1994.

Royal College of Obstetricians and Gynaecologists. The investigation and management of the small for gestational age; 2002.

Platz E, Newman R. Diagnosis of IUGR: traditional biometry. Semin Perinatol 2008;32:140-7.

Neilson JP. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev 2000;(2): CD000944.

Baschat AA. Fetal responses to placental insufficiency: an update. BJOG 2004;111:1031-41.

Baschat AA. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv 2004;59:617-27.

Resnik R. Intrauterine Growth Restriction. Obstet Gynecol 2002;99:490-6.

Turan S, Miller J, Baschat AA.Integrated testing and management in fetal growth restriction. Semin Perinatol 2008;32:194-200.

Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev 2008;(3):CD006593.

LalorJG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2008;(1): CD000038.

Nielson JP, Alfirevic Z.Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2000;(2):CD000073.

Maulik D. Doppler Ultrasound in Obstetrics and Gynecology. 2nd ed. Heidelberg, Germany: Springer; 2005.

Mari G, Picconi J.Doppler vascular changes in intrauterine growth restriction. Semin Perinatol 2008;32:182-9.

Harman CR, Baschat AA. Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed? Curr Opin Obstet Gynecol 2003;15:147-57.

Sebire NJ.Umbilical artery Doppler revisited: pathophysiology of changes in intrauterine growth restriction revealed. Ultrasound Obstet Gynecol 2003;21:419-22.

Baschat AA, Gembruch U, Weiner CP, Harman CR. Qualitative venous Doppler waveform analysis improves prediction of critical perinatal outcomes in premature growth-restricted fetuses. Ultrasound Obstet Gynecol 2003;22:240-5.

Baschat AA, Weiner C. Umbilical artery Doppler screening for detection of the small fetus in need of antepartum surveillance. Am J Obstet Gynecol 2000;182:154-8.

Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001;18:564-70.

Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001;18:571-7.

Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008;32:274-80.

Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, et al. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;32:160-7.

Turan S, Turan OM, Berg C, Moyano D, Bhide A, Bower S, et al. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses. Ultrasound Obstet Gynecol 2007;30:750-6.

Coria-sotoIL, Bobadilla JL, Notzon F. The effectiveness of antenatal care in preventing intrauterine growth retardation and low birth weight due to preterm delivery. Int J Qual Health Care 1996;8:13-20.

Lu MC, Tache V, Alexander GR, Kotelchuck M, Halfon N. Preventing low birth weight: is prenatal care the answer? J Matern Fetal Neonatal Med 2003;13:362-80.

Villar J, Merialdi M, Gülmezoglu AM, Abalos E, Carroli G, Kulier R, de Onis M. Characteristics of randomized controlled trials included in systematic reviews of nutritional inter ventions reporting maternal morbidity, mortality, preterm delivery, intrauterine growth restriction and small for gestational age and birth weight outcomes. J Nutr 2003;133:1632S-1639S.

de Onis M, Villar J, Gülmezoglu M. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials. Eur J Clin Nutr 1998;52:S83-93.

Gülmezoglu M, de Onis M, Villar J. Effectiveness of interventions to prevent or treat impaired fetal growth. Obstet Gynecol Surv 1997;52:139-48.

Trudinger BJ, Cook CM, Thompson RS, Giles WB, Connelly A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988;159:681-5.

CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619-29.

Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:450-9.

Italian study of aspirin in pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993;341:396-400.

HarringtonK, Kurdi W, Aquilina J, England P, Campbell S. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks. Ultrasound Obstet Gynecol 2000;15:13-8.

Yu CK, Papageorghiou AT, Parra M, Dias RP, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003;22:233-9.

Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a metaanalysis. Obstet Gynecol 2001;98:861-6.

Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161-7.

Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 2005;46:826-31.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;30:918-32.

Pihl K, Larsen T, Krebs L, Christiansen M. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn 2008;28:1131-5.

Mari G, Hanif F, Treadwell MC, Kruger M. Gestational age at delivery and Doppler waveforms in very preterm intrauterine growth-restricted fetuses as predictors of perinatal mortality. J Ultrasound Med 2007;26:555-9.

Say L, Gülmezoglu AM, Hofmeyr GJ.Maternal nutrient supplementation for suspected impaired fetal growth. Cochrane Database Syst Rev 2003;(1): CD000148.

Say L, Gülmezoglu AM, Hofmeyr GJ. Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database Syst Rev 2003;(1):CD000137.

Say L, Gülmezoglu AM, Hofmeyr GJ. Hormones for suspected impaired fetal growth. Cochrane Database Syst Rev 2003;(1):CD000109.

Baschat AA, Galan HL, Bhide A, Berg C, Kush ML, Oepkes D, et al. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol 2006;27:41-7.

ACOG Practice Bulletin.Clinical Management Guidelines for Obstetrician-Gynecologists, Number 70, December 2005 (Replaces Practice Bulletin Number 62, May 2005). Intrapartum fetal heart rate monitoring. Obstet Gynecol 2005; 106:1453-60.

Devoe L, Golde S, Kilman Y, Morton D, Shea K, Waller J. A comparison of visual analyses of intrapartum fetal heart rate tracings according to the new National Institute of Child Health and Human Development guidelines with computer analyses by an automated fetal heart rate monitoring system. Am J Obstet Gynecol 2000;183:361-6.

Pardey J, Moulden M, Redman CW. A computer system for the numerical analysis of nonstress tests. Am J Obstet Gynecol 2002;186:1095-103.

Cosmi E, Ambrosini G, D'Antona D, Saccardi C, Mari G. Doppler, cardiotocography, and biophysical profile changes in growth-restricted fetuses. Obstet Gynecol 2005;106:1240-5.

Baschat AA.Integrated fetal testing in growth restriction: combining multivessel Doppler and biophysical parameters. Ultrasound Obstet Gynecol 2003;21:1-8.

Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364:513-20.

Baschat AA, Gembruch U.The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003;21:124-7.

Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of blood velocity and pulsatility index at the intraabdominal portion, and fetal and placental ends of the umbilical artery. Ultrasound Obstet Gynecol 2005;26:162-9.

Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005;192:937-44.

Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128-32.

Kessler J, Rasmussen S, Hanson M, Kiserud T. Longitudinal reference ranges for ductus venosus flow velocities and waveform indices. Ultrasound Obstet Gynecol 2006;28:890-8.

Fouron JC. The unrecognized physiological and clinical significance of the fetal aortic isthmus. Ultrasound Obstet Gynecol 2003;22:441-7.

Ruskamp J, Fouron JC, Gosselin J, Raboisson MJ, Infante-Rivard C, Proulx F. Reference values for an index of fetal aortic isthmus blood flow during the second half of pregnancy. Ultrasound Obstet Gynecol 2003;21:441-4.

Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-lowbirth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198-206.

Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109:253-61.

Mari G,Hanif F, Kruger M. Sequence of cardiovascular changes in IUGR in pregnancies with and without preeclampsia. Prenat Diagn 2008;28:377-83.

Mari G, Hanif F, Kruger M, Cosmi E, Santolaya-Forgas J, Treadwell MC. Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of IUGR fetuses. Ultrasound Obstet Gynecol 2007;29:310-6.

Confidential Enquiry into Stillbirths and Deaths in Infancy. Annual Report for 1 January - 31 December 1993. London: HMSO; 1996.

Spinillo A, Capuzzo E, Stronati M, Ometto A, De Santolo A, Acciano S. Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol 1998;105:865-71.

Amato M, Konrad D, Hüppi P, Donati F. Impact of prematurity and intrauterine growth retardation on neonatal hemorrhagic and ischemic brain damage. Eur Neurol 1993;33:299-303.

Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M; The GRIT study Group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomized controlled trial. Lancet 2004;364:513-20.

Tyson RW, Staat BC.The Intrauterine growth restricted fetus and placenta evaluation. Semin Perinatol 2008;32:166-71.

Hales CN, BarkerDJ. The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20.

Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet 2004;363:1642-5.

Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, et al. Premature birth and later insulin resistance. N Engl J Med 2004;351:2179-86.

Publicado
2009-09-30
Cómo citar
1.
Sanín-Blair JE, Gómez-Díaz J, Ramírez J, Mejía CA, Medina Óscar, Vélez J. Diagnóstico y seguimiento del feto con restricción del crecimiento intrauterino (RCIU) y del feto pequeño para la edad gestacional (PEG). Consenso Colombiano*. Rev. Colomb. Obstet. Ginecol. [Internet]. 30 de septiembre de 2009 [citado 21 de septiembre de 2021];60(3):247-61. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/330
Sección
Artículo de Revisión
Crossref Cited-by logo